How Purdue, the Sacklers and the FDA turned a painkiller into 500,000 dead Americans.
The opioid crisis wasn't an accident — it was a marketing plan. This timeline tracks Purdue's fake pain society, the doctored clinical trials, the DEA enforcement that got killed, and the Sackler fortune that walked away with billions.
Internal Merck emails showed executives knew Vioxx doubled heart attack risk but suppressed studies and intimidated researchers. The company withdrew Vioxx only after external studies proved cardiovascular dangers.
Internal Merck emails showed executives knew Vioxx doubled heart attack risk as early as 1997. The company suppressed studies and attacked researchers who questioned its safety until 2004 withdrawal.
Internal Purdue documents showed executives knew OxyContin caused addiction and overdoses while marketing it to doctors as having low abuse potential.
Internal documents showed Purdue executives knew OxyContin was highly addictive but trained sales reps to claim 12-hour dosing reduced addiction risk compared to other opioids.
Court filings revealed Purdue executives received reports of widespread OxyContin abuse and addiction by 2000 but continued aggressive marketing claiming low addiction potential until 2007.
McKinsey & Company worked on 37 FDA contracts while simultaneously consulting for Purdue Pharma on strategies to boost OxyContin sales, a massive conflict of interest they never disclosed to the FDA. McKinsey used its government work to solicit business from opioid manufacturers and tried to influence Trump HHS Secretary Alex Azar for private opioid clients. In July 2018, senior partners discussed destroying their Purdue documents, with one emailing himself a note to 'delete old pur documents from laptop.' McKinsey paid $650 million to resolve criminal and civil investigations.
Court documents revealed pharmaceutical companies coordinated to promote opioids for chronic pain despite knowing addiction risks, funding fake patient advocacy groups and medical conferences.
Court documents revealed Sackler family members personally directed Purdue's aggressive opioid marketing strategies while privately acknowledging addiction risks.
'Milking program': $11B to offshore 2008-2018. 900K opioid deaths. Felony 2007. Settlement: $7.4B. Zero prison.
Advised 'turbocharge' sales. Proposed rebates per overdose. Countered DEA. $573M settlement. Admitted destroying docs.
McKesson, Cardinal Health, and AmerisohnBergen ignored obvious red flags and shipped millions of suspicious opioid orders to pill mills, despite legal obligations to report and halt suspicious shipments.
Every entry on this timeline started as a tip. If you have documentation, a court filing, a leaked memo or a screenshot — drop it.
+ Drop a Receipt
